Diagnostic Utility of the Gilliam Autism Rating Scales-3rd Edition Parent Report in Clinically Referred Children.

Researchers tested how well the GARS-3 autism screening tool works when filled out by parents. They studied 186 children who were referred for possible autism diagnosis. The tool performed poorly - it only correctly identified about half the children and had very high rates of false positives (saying a child might have autism when they don't). The researchers concluded that the GARS-3 is not reliable enough for use in community settings where children have complex needs.

This study evaluated the diagnostic accuracy of the GARS-3 parent report form in 186 clinically referred children (mean age 8.98 years) suspected of autism. Participants received comprehensive evaluations including the ADOS-2, with 87 receiving autism diagnoses and 99 not receiving autism diagnoses. The GARS-3 showed poor diagnostic performance, with the recommended cutoff score of 70 correctly classifying only 47% of participants. False positive rates were extremely high (82.83-87.88%), meaning many non-autistic children were incorrectly identified as potentially autistic.

Correlations with the ADOS-2 were significantly lower than reported in the standardization sample, and sensitivity/specificity could not be optimized.

The GARS-3 parent report should not be used as a standalone diagnostic tool in community clinical settings due to poor accuracy and high false positive rates. Clinicians should rely on comprehensive assessments including tools like the ADOS-2 rather than the GARS-3 for autism evaluation in complex cases.

Study focused on clinically referred children which may not represent the general population. The abstract does not specify the study design methodology or provide detailed demographic information beyond age. No information provided about inter-rater reliability or other validation measures.

There is limited research regarding the Gilliam Autism Rating Scales-3rd Edition (GARS-3) despite its extensive use. A comprehensive diagnostic evaluation, including the Autism Diagnostic Observation Schedule-2nd Edition (ADOS-2) was provided to 186 clinically referred children suspected of autism ([Formula: see text] age = 8.98; Autism [AUT] n = 87; Not Autism [NOT] n = 99). Mean difference analyses, Logistic Regressions, and ROC analyses were non-significant for both Autism Index scores. The author-suggested cutoff score of 70 correctly classified approximately 47% of participants, with false positive rates = 82.83-87.88%.

ADOS-2 correlations were significantly lower vis-à-vis the standardization sample. The Social Interaction subscale demonstrated weak, marginal results, and sensitivity/specificity could not be optimized. In its current form, the GARS-3 does not demonstrate adequate criterion validity for use in assessment of complex community samples.